Research graph
References from SEME enables programmable transcript reconstruction through synthetic microexon incorporation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrg.2015.3
10.1038/nrg.2015.3 · External reference
Dysregulation and therapeutic targeting of RNA splicing in cancer
10.1038/s43018-022-00384-z · 2022 · External reference
10.1038/s41583-023-00717-6
10.1038/s41583-023-00717-6 · External reference
10.1038/s41569-022-00828-0
10.1038/s41569-022-00828-0 · External reference
10.1016/j.ajhg.2021.09.014
10.1016/j.ajhg.2021.09.014 · External reference
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data
10.1038/s41467-024-55185-y · 2025 · External reference
10.1038/nbt0918-899c
10.1038/nbt0918-899c · External reference
10.1101/400341
10.1101/400341 · External reference
Large DNA deletions occur during DNA repair at 20-fold lower frequency for base editors and prime editors than for Cas9 nucleases
2025 · External reference
10.1038/s41467-023-37507-8
10.1038/s41467-023-37507-8 · External reference
Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy
10.1016/j.xcrm.2024.101901 · 2025 · External reference
10.1161/circulationaha.117.028382
10.1161/circulationaha.117.028382 · External reference
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
10.1016/j.omtm.2021.05.014 · 2021 · External reference
10.1016/j.ymthe.2025.09.038
10.1016/j.ymthe.2025.09.038 · External reference
10.1126/scitranslmed.3008873
10.1126/scitranslmed.3008873 · External reference
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 · External reference
Structural Perturbations of Exon-Skipping Edits within the Dystrophin D20:24 Region
10.1021/acs.biochem.0c00827 · 2021 · External reference
Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
10.1016/j.xpro.2021.100334 · 2021 · External reference
Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/beta-catenin signal pathway
10.1093/cvr/cvae098 · 2024 · External reference
10.1038/nrm4063
10.1038/nrm4063 · External reference
10.7554/elife.64911
10.7554/elife.64911 · External reference
10.1161/circresaha.120.317076
10.1161/circresaha.120.317076 · External reference
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy
10.1126/sciadv.abk0052 · 2022 · External reference
10.1161/circresaha.123.322750
10.1161/circresaha.123.322750 · External reference
10.1016/j.ajhg.2021.09.014
10.1016/j.ajhg.2021.09.014 · ExternalCitation · doi-reference
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
10.1016/j.omtm.2021.05.014 · ExternalCitation · doi-reference
Phase 1/2 trial of brogidirsen: Dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy
10.1016/j.xcrm.2024.101901 · ExternalCitation · doi-reference
Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes
10.1016/j.xpro.2021.100334 · ExternalCitation · doi-reference
10.1016/j.ymthe.2025.09.038
10.1016/j.ymthe.2025.09.038 · ExternalCitation · doi-reference
Structural Perturbations of Exon-Skipping Edits within the Dystrophin D20:24 Region
10.1021/acs.biochem.0c00827 · ExternalCitation · doi-reference
10.1038/nbt0918-899c
10.1038/nbt0918-899c · ExternalCitation · doi-reference
10.1038/nrg.2015.3
10.1038/nrg.2015.3 · ExternalCitation · doi-reference
10.1038/nrm4063
10.1038/nrm4063 · ExternalCitation · doi-reference
10.1038/s41467-023-37507-8
10.1038/s41467-023-37507-8 · ExternalCitation · doi-reference
Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data
10.1038/s41467-024-55185-y · ExternalCitation · doi-reference
10.1038/s41569-022-00828-0
10.1038/s41569-022-00828-0 · ExternalCitation · doi-reference
10.1038/s41583-023-00717-6
10.1038/s41583-023-00717-6 · ExternalCitation · doi-reference
Dysregulation and therapeutic targeting of RNA splicing in cancer
10.1038/s43018-022-00384-z · ExternalCitation · doi-reference
Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/beta-catenin signal pathway
10.1093/cvr/cvae098 · ExternalCitation · doi-reference
10.1101/400341
10.1101/400341 · ExternalCitation · doi-reference
Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy
10.1126/sciadv.abk0052 · ExternalCitation · doi-reference
10.1126/scitranslmed.3008873
10.1126/scitranslmed.3008873 · ExternalCitation · doi-reference
10.1161/circresaha.120.317076
10.1161/circresaha.120.317076 · ExternalCitation · doi-reference
10.1161/circresaha.123.322750
10.1161/circresaha.123.322750 · ExternalCitation · doi-reference
10.1161/circulationaha.117.028382
10.1161/circulationaha.117.028382 · ExternalCitation · doi-reference
10.7554/elife.64911
10.7554/elife.64911 · ExternalCitation · doi-reference
